Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Results From the Randomized Phase III RESONATE™ (PCYC-1112) Trial
Title:
Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Results From the Randomized Phase III RESONATE™ (PCYC-1112) Trial
Author:
Brown, J. Jennifer R. Byrd, John C. O’Brien, Susan Barrientos, Jacqueline C. Kay, Neil E. Reddy, Nishitha M. Coutre, Steven Tam, Constantine S. Mulligan, Stephen Jaeger, Ulrich Devereux, Stephen Barr, Paul M. Furman, Richard Kipps, Thomas Cymbalista, Florence Fardis, Maria McGreivy, Jesse Clow, Fong James, Danelle F. Hillmen, Peter